Schonfeld Strategic Advisors LLC - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 172 filers reported holding ARRAY BIOPHARMA INC in Q3 2016. The put-call ratio across all filers is 1.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$1,339,000
-92.0%
28,900
-95.8%
0.05%
-91.9%
Q1 2019$16,728,000
+166.3%
686,100
+55.6%
0.58%
+140.1%
Q4 2018$6,282,000
-22.3%
440,800
-17.1%
0.24%
-32.6%
Q3 2018$8,082,000
+60.8%
531,700
+77.5%
0.36%
+31.5%
Q2 2018$5,026,000
+145.8%
299,500
+139.0%
0.27%
+78.4%
Q1 2018$2,045,000
+1485.3%
125,312
+1146.3%
0.15%
+1290.9%
Q4 2017$129,000
-84.2%
10,055
-91.7%
0.01%
-92.1%
Q3 2016$819,000121,3090.14%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q3 2016
NameSharesValueWeighting ↓
BVF INC/IL 9,169,276$66,110,00011.67%
Redmile Group, LLC 13,623,620$98,226,0008.05%
First Light Asset Management, LLC 849,374$6,124,0002.88%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 9,529,361$68,707,0002.29%
Opus Point Partners Management, LLC 320,000$2,307,0001.83%
KOPP INVESTMENT ADVISORS LLC 383,022$2,762,0001.23%
Artal Group S.A. 3,710,000$26,749,0001.15%
EcoR1 Capital, LLC 400,000$2,884,0000.96%
Cormorant Asset Management, LP 850,000$6,129,0000.82%
SPHERA FUNDS MANAGEMENT LTD. 800,000$5,768,0000.56%
View complete list of ARRAY BIOPHARMA INC shareholders